Company profile
Fulcrum Therapeutics, Inc. Insider Trading
FULCEvery SEC Form 4 insider trading filing for Fulcrum Therapeutics, Inc. (FULC) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001680581
- Filings
- 65
- Insiders
- 22
- Last filing
- 2026-07-17
Activity summary
No insider transactions in the last 30 days. The most recent was on July 17, 2026, when Kevin Tang bought 50,945 shares. 65 filings from 22 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Fulcrum Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $58.6M.
90 day insight
Over the last 90 days, Fulcrum Therapeutics, Inc. insiders bought $1.5M across 14 transactions with no open-market sales.
- Most active insider: Kevin Tang with 6 transactions totaling $1.5M.
- Largest single purchase: $415K by Kevin Tang on Jul 16, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | Kevin Tang | FULC | Purchase | 50,945 | $3.52 | $179K |
| Jul 16, 2026 | Kevin Tang | FULC | Purchase | 116,671 | $3.56 | $415K |
| Jul 15, 2026 | Kevin Tang | FULC | Purchase | 107,377 | $3.56 | $382K |
| Jul 14, 2026 | Kevin Tang | FULC | Purchase | 53,651 | $3.56 | $191K |
| Jul 14, 2026 | Kevin Tang | FULC | Purchase | 75,952 | $3.58 | $272K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=FULC" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Fulcrum Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →